Difficulty swallowing , known medically as dysphagia , and acid reflux are two conditions that frequently occur together, and the relationship between them is more complex than it first appears. Reflux can directly damage the esophagus in ways that make swallowing harder. And dysphagia itself can worsen reflux by altering how the esophagus clears acid. Understanding how these two conditions interact is essential for anyone who has been managing reflux without finding full relief.
How Acid Reflux Leads to Swallowing Difficulties
The esophagus is not designed for repeated acid exposure. When stomach acid refluxes into the esophagus consistently over months or years, it causes inflammation , a condition called erosive esophagitis. Over time, this inflammation can trigger scar tissue formation, narrowing the internal diameter of the esophagus in a process known as a peptic stricture. Once a stricture develops, solid foods , particularly bread, meat, and dense textures , can become difficult to swallow or feel as though they are getting stuck. A 2024 review in Best Practice & Research: Clinical Gastroenterology confirms that long-term acid exposure is directly associated with peptic stricture and Barrett’s esophagus as downstream complications.
Barrett’s esophagus , where the normal esophageal lining is replaced by intestinal-type tissue , is the primary recognised precursor to esophageal adenocarcinoma. A 2026 review published in the Annals of the New York Academy of Sciences confirms that Barrett’s esophagus is the main precursor lesion arising from chronic GERD, and underscores why persistent, unmanaged reflux warrants proper medical evaluation rather than long-term self-management.
When Reflux Isn’t the Only Cause: Eosinophilic Esophagitis
One of the most commonly missed diagnoses in people with both reflux symptoms and swallowing difficulties is eosinophilic esophagitis (EoE) , a chronic immune-mediated condition in which eosinophils (a type of white blood cell) accumulate in the esophageal lining, causing inflammation and progressive narrowing.
EoE can mimic GERD almost exactly: patients experience heartburn, chest discomfort, and difficulty swallowing. The critical distinguishing factor is that EoE does not reliably respond to PPI therapy alone. When a patient’s reflux symptoms fail to improve after an adequate trial of high-dose PPIs, EoE should be evaluated via upper endoscopy with biopsy.
The diagnostic threshold for EoE is 15 or more eosinophils per high-power field on esophageal biopsy. A study in Internal Medicine confirms this histopathological threshold and demonstrates that endoscopic features , including white plaques, vertical furrows, and circular rings , are characteristic of EoE but must always be confirmed by biopsy, as asymptomatic esophageal eosinophilia can share the same endoscopic appearance without meeting diagnostic criteria for EoE.
Diagnostic Tools Used to Evaluate Dysphagia and Reflux
When a patient presents with both swallowing difficulties and reflux symptoms, clinicians typically use a combination of the following:
Upper endoscopy (EGD) – the primary tool for directly visualising the esophageal lining, identifying strictures, erosions, Barrett’s changes, or the endoscopic features of EoE. Biopsies can be taken at the same time.
Ambulatory pH monitoring – measures actual acid exposure in the esophagus over 24 hours, helping distinguish pathological reflux from functional symptoms.
Esophageal manometry – assesses the pressure and motility of the esophagus, identifying conditions such as achalasia or ineffective esophageal motility that can cause or worsen dysphagia.
Barium swallow / upper GI series – useful for identifying structural abnormalities, strictures, or hiatal hernias not immediately visible on endoscopy.
Treatment Approaches: What the Evidence Shows
Treatment for dysphagia associated with reflux depends heavily on the underlying cause.
Proton Pump Inhibitors (PPIs)
PPIs are the first-line pharmacological treatment for erosive GERD and reflux-related esophageal damage. They are effective at maintaining intragastric pH above 4 for extended periods and significantly outperform H2-receptor antagonists in healing erosive esophagitis. However, a review published in Diseases of the Esophagus found that up to 40% of patients with GERD report persistent symptoms despite PPI therapy, and identified multiple potential mechanisms behind treatment failure including metabolic factors and non-acid reflux mechanisms.
Esophageal Dilation
For patients who have developed esophageal strictures, endoscopic dilation is a well-established and effective intervention. It involves widening the esophageal lumen using graduated dilators or balloon catheters under endoscopic guidance. Symptom relief is typically rapid, though strictures may recur in patients with ongoing acid exposure, making concurrent acid management essential.
Treatment for Eosinophilic Esophagitis
EoE requires a different treatment strategy from GERD. The main options are dietary therapy, topical corticosteroids, and , where significant narrowing has occurred , endoscopic dilation.
Dietary elimination involves removing the most common allergenic trigger foods to reduce esophageal inflammation. A review published in Current Opinion in Clinical Nutrition and Metabolic Care found that the six-food empiric elimination diet (removing milk, wheat/gluten, egg, soy/legumes, nuts, and fish/seafood) achieved histological remission in approximately 72% of children studied, with milk, egg, and wheat being the most frequently identified triggers. Importantly, the review notes that less restrictive step-up strategies , removing fewer foods first , can reduce the number of endoscopic procedures required while still achieving good remission rates in many patients.
Budesonide orodispersible tablets (BOT) are the most rigorously studied pharmacological treatment for EoE. According to PubMed, a phase 3 randomised controlled trial published in Gastroenterology found that 73.5–75% of EoE patients treated with BOT maintained remission at 48 weeks, compared to only 4.4% on placebo , a highly significant difference. Both the 0.5 mg and 1.0 mg twice-daily dosages performed equally well and were well tolerated, with candidiasis the most common side effect (reported in approximately 11–16% of patients, all cases resolved with treatment).
Endoscopic dilation in EoE is used when medication and dietary therapy have not sufficiently reduced esophageal narrowing. The procedure carries a small risk of esophageal perforation and should be performed by experienced endoscopists.
Surgical Options for Refractory GERD
For patients with structural GERD that does not respond adequately to medical management, laparoscopic anti-reflux surgery is an option. Decisions about surgical intervention should always be made in consultation with a specialist gastroenterologist or foregut surgeon, with careful discussion of potential complications including post-operative dysphagia.
The Role of Swallowing Therapy and Multidisciplinary Care
For patients whose dysphagia has a neuromuscular or functional component , rather than purely structural , swallowing therapy delivered by a speech and language pathologist (SLP) is an important part of care. SLPs assess swallowing mechanics, recommend appropriate food textures and liquid consistencies, and guide patients through exercises that support swallowing coordination.
The International Dysphagia Diet Standardisation Initiative (IDDSI) framework provides a globally recognised system for describing and prescribing texture-modified foods and thickened liquids , a practical tool for both patients and clinicians managing dysphagia safely at home.
In complex cases involving both reflux and dysphagia, care is ideally coordinated between a gastroenterologist, SLP, dietitian, and , where relevant , an allergist or immunologist for EoE. Research consistently shows that multidisciplinary care produces better outcomes than single-specialty management for this patient population.
Lifestyle Modifications That Support Recovery
Regardless of the underlying cause, several lifestyle changes consistently support better outcomes in people managing reflux-associated dysphagia. Eating smaller, more frequent meals reduces pressure on the lower esophageal sphincter. Avoiding known dietary triggers , including high-fat meals, caffeine, alcohol, and acidic foods , reduces symptom burden. Remaining upright for at least two to three hours after eating prevents gravity from working against esophageal clearance.
For those with nocturnal symptoms, a systematic review published in Neurogastroenterology and Motility found that a sequential strategy of head-of-bed elevation, prolonging the dinner-to-bed interval, and lying in the left lateral position , combined with acid-suppressive medication , is the evidence-based recommended approach for nocturnal GERD. Notably, the review found insufficient evidence to recommend hypnotics, baclofen, or adding a bedtime H2 receptor antagonist as routine interventions.
Weight management is also a recognised factor: excess abdominal adiposity increases intra-abdominal pressure and is a mechanical contributor to GERD.
When to Seek Medical Attention
Dysphagia should never be self-managed or attributed to reflux without proper evaluation. Symptoms that warrant prompt medical assessment include:
- Food getting stuck in the throat or chest
- Progressive difficulty swallowing solids, then liquids
- Unintentional weight loss
- Regurgitation of undigested food
- Pain on swallowing (odynophagia)
- Choking or coughing during meals
- Persistent hoarseness or voice changes
These symptoms may indicate conditions ranging from esophageal stricture to EoE to esophageal malignancy , all of which require formal diagnosis.
Frequently Asked Questions
Can acid reflux cause permanent damage to the esophagus? Yes, chronic untreated reflux can cause erosive esophagitis, esophageal strictures, and Barrett’s esophagus. Barrett’s esophagus is the main recognised precursor to esophageal adenocarcinoma, which is why persistent symptoms warrant medical evaluation rather than long-term self-management.
How do doctors tell the difference between GERD and EoE? The two conditions can produce almost identical symptoms. The key distinguishing factor is response to PPI therapy: GERD typically improves with PPIs, while EoE frequently does not. Biopsy via upper endoscopy confirms EoE when eosinophil counts exceed 15 per high-power field.
Is swallowing therapy effective for reflux-related dysphagia? Where dysphagia has a functional or neuromuscular component, swallowing therapy from a speech and language pathologist can significantly improve outcomes. For structural causes such as strictures, therapy is typically used alongside dilation and acid management rather than as a standalone treatment.
What should I do if food gets stuck when I swallow? Seek medical evaluation promptly. Food impaction can be a symptom of esophageal stricture, EoE, or other structural conditions. Recurrent impaction requiring emergency intervention is a clear signal that formal investigation , including endoscopy , is needed.
Explore Expert-Led Guidance on Reflux and Swallowing
If this article has raised questions about your own experience, the Reflux Online Summit was created to help you go further. Leading specialists in gastroenterology, functional medicine, ENT, and integrative health share what actually works for complex, treatment-resistant reflux, including conditions that involve both reflux and swallowing difficulties.
Attendance is free. Reserve your spot at refluxsummit.com →
